Data is not available at this time.
O.B.System Inc. operates as a specialized system integration service provider in Japan, focusing on tailored IT solutions for diverse industries, including finance, healthcare, and public sectors. The company’s core revenue model revolves around developing and implementing custom software applications, network systems, and internet/web solutions, with a strong emphasis on medical information systems like CLIP and MEX-Plus. Its niche expertise in clinical laboratory and medical examination systems positions it as a trusted partner for healthcare institutions, while its broader IT integration services cater to industrial and financial clients. The firm’s long-standing presence since 1972 and headquarters in Chuo, Japan, underscore its established market position in a competitive IT services landscape. Unlike generalist IT firms, O.B.System differentiates itself through domain-specific solutions, particularly in healthcare IT, where regulatory and technical complexities create high barriers to entry. This focus allows the company to maintain steady demand despite broader economic fluctuations.
In FY2025, O.B.System reported revenue of ¥7.68 billion, with net income of ¥485 million, reflecting a net margin of approximately 6.3%. The company’s diluted EPS stood at ¥210.57, supported by disciplined cost management. Operating cash flow of ¥462 million, against modest capital expenditures of ¥30.3 million, indicates efficient cash conversion from core operations.
The firm demonstrates stable earnings power, with no debt on its balance sheet and a cash reserve of ¥2.64 billion, providing significant liquidity. Its capital-light model, evidenced by low capex relative to operating cash flow, underscores efficient asset utilization and flexibility for strategic investments or shareholder returns.
O.B.System maintains a robust financial position, with zero debt and cash equivalents representing over 34% of its market capitalization. This conservative capital structure minimizes financial risk and supports resilience in economic downturns, while offering ample room for organic growth or acquisitions.
The company’s growth is tied to Japan’s IT modernization trends, particularly in healthcare digitization. Its dividend payout of ¥80 per share suggests a commitment to returning capital, with a yield of approximately 3.8% based on current market cap, appealing to income-focused investors in a low-interest-rate environment.
At a market cap of ¥5.63 billion, the stock trades at a P/E of ~11.6x (based on diluted EPS), below the sector median, reflecting its niche focus and modest growth expectations. The low beta of 0.42 indicates lower volatility relative to the broader market, aligning with its stable cash flows and defensive business model.
O.B.System’s deep expertise in healthcare IT and long-term client relationships provide a competitive moat. While Japan’s aging population and healthcare digitization trends offer tailwinds, the company’s reliance on domestic demand and limited scale pose challenges. Strategic partnerships or overseas expansion could unlock future growth.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |